chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child had an episode the morning after immunizations.  She called for help in her morning shower.  Mom found her sitting on floor.  She attempted to vomit.  Mom got her up.  She went limp for a few seconds.  Mom thought pupils were dilated.  No fever, no abdominal pain, no known seizure activity.
Headache and body ache, tiredness about 12 hrs after receiving 2nd dose continuing until 24 hrs after receiving.  Swollen lymph node on injection side noticed second morning after shot administered, continued into 3rd day after 2nd dose.
Patient was given Menveo in error. She has received Menactra 7/28/15 and another dose of Menveo 7/13/21. Patient was only due for Bexsero on 8/13/21, but was given Bexsero and Menveo. This dose of Menveo was given less than 8 weeks after previous dose, which is the minimum interval. Patient did not report any adverse side effects.
Very intense, recurring and persistent migraine-type headaches, intensity increasing for hours at a time, unaffected by sleep or wakefullness, unaffected by activity or stationary sitting; unafected by over the counter medications but somehat relieved by rizotriptan.  Dose limited to two daily but entirely insufficient.  Persistant, nearly constant headache has lasted for seven days following administration of the second Pfizer dose.  Also, minor to significant interruptions in standing or rising balance but this was substantially  worse during severe headache occurence.
Woke up with the injection site feeling very hot and painful. Pain level is worse than I typically experience with my fibromyalgia, as a point of comparison. Have been very tired all day and slept approximately 13 hours total from when I went to bed last night to when I finally got out of bed today. Heat is still present but has died down; pain and fatigue are about the same as when I woke up in the morning.
Redness, swelling from left shoulder to elbow. Slight lymph node enlargement-axilla.
Patient presented today, approximately one week after receiving PREVNAR 13 in her Left deltoid muscle. Patient's arm was red, swollen, and hot to to the touch. I instructed the patient to see her physician as this has been documented at other pharmacies I have visited.
rash covering my chest with intensr itching. shingles was diagonesedand an anti viral was prescribed --VALACYCLOVIR-1 GRAM-20 PILLS
I woke up the following morning and had a fever of 101. I have normal migraines but felt like I had been hit in the back of the head with a sledgehammer. It was so intense. I was not able to function as I normally do. I called into work sick, but remember throughout the day, I tried to respond to texts and e-mails and would try and fall back asleep. I was so weak, and my entire body hurt. I talked to my mom and husband on the phone and do not have any recollection of doing so. I didn't have a fever by that night. The next day, I worked from home but was still so weak and tired I had to take off and keep taking naps. The 3rd day, I finally started getting a little of my strength back and wasn't as tired. I continued to improve over the next two days; five days total.
LOSING CONSCIOUSNESS; This spontaneous report received from a patient via social media concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced losing consciousness 25 minutes after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of Losing consciousness was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:-covid-19 vaccine ad26.cov2.s-losing consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Vial used for this dose was first punctured on 6/7/22. This patient received the vaccine on 6/10/22 around 72 hours since first puncture.   The vial had been stored in the fridge since 6/7/22. Patient does not report any unusual side effects. Patient will continue to monitor symptoms and report back. Per CDC guidance, patient will re-do the booster dose when convenient for him.
Patient developed severe shortness of breath.   Patient went to the ER and was admitted.   Diagnosis - heart failure
Red rash and itching on large portion of right arm, starting a couple days after injection and continuing currently.
Headache, fever, chills, body aches, fatigue and nausea. All symptoms lasted 48 hours except nausea that lasted 72 hours.
Patient had previously received the Janssen (J&J) vaccine at Practice on 3/31/2021.  This violates the EUA for both vaccine parameters.
From Dec 26-29, 2020, I had injection site pain. On Jan 4, 2021, I had ear pain and it went away in two days. On Jan 7, 2021, I had mild pain on my armpit and left shoulder (Note: my left shoulder had an injury ~ 3 years ago. However, it only has pain now and then when the weather is cold or on rainy days). The pain on my armpit went away on Jan 15, 2021.   The mild pain in my left shoulder is still there. On Jan 9, 2021, I got a ~8 cm in diameter BCG-like rash with induration on the edges. I took Claritin one time a day for six days, and alternate Tylenol and Motrin every 12 hours for six days. It got better on Jan 12, 2021. Now the rash is almost gone.
Client received MMR and varicella vaccines too early at age 10 months. No adverse effects reported at this time.
Patient received vaccination at approximately 2:15pm. She received education on signs/symptoms to monitor for post-vaccination. She was asked to sit in the waiting room for her 15 minute observation time (per our policy) with staff at side. At approximately 2:36pm, she was packing her items to leave the site as her observation time had ended. At this time she reported to staff that she felt a "lump" in her throat. RN was notified and arrived to patient's side. RN assessed patient and assisted her to the back medication room. At this time the patient reported to RN "lump" in throat WITHOUT shortness of breath or hoarsness/stridor, slight nausea, and RN observed pallor and clamminess around face and neck. VS were still stable at this time. At approximately 2:46pm, 0.3mg of epinephrine was administered via EpiPen Auto Injector per our policy. EMS were called at 2:47pm and arrived at 2:50pm. VS were continuously be assessed and remained stable with the exception of slightly elevated blood pressure (148/82) after the administration of epinephrine. Patient did not appear to be in distress. Continued to deny shortness of breath or any respiratory involvement. Patient reported at 2:49pm "I am feeling much better after that medication" and "the lump is going away".  EMS and family were now at side. EMS completed their workup. Patient refused EMS services and refused to go to Emergency room per MD order and EMS . VS remained stable. By 3:03pm the patient had much improved pallor and no longer had observable clamminess of the skin. EMS left at approximately 3:06pm. Patient continued to refuse additional treatment, however, RN and other medical staff provided necessary education on signs/symptoms to assess for throughout the day and evening and the coming days. The Medical Director was on the phone with RN after the administration of epi and was providing continued guidance and education to patient. Education was also given to patient regarding monitoring vital signs, foods/medications/known allergens to avoid in the coming days. She was also educated on the absolute need for follow up with a healthcare provider due to her severe reaction. She was also advised on how to proceed with future COVID vaccinations if there were to be any in the future. Patient's daughter was at her side during all educations. Both daughter and patient verbalized understanding. Patient DID sign an AMA form for EMS. At the time that the patient departed, her VS were back to her normal baseline and stable, patient was not in distress and denies all signs/symptoms and any pain or discomfort. Her skin was warm and dry and breathing was regular. No stridor or hoarseness observed/heard.
31MAR92 AM t101, irritable, no appetite; sx continue w/fever increasing; 3APR92 AM t104.2 to MD ordered APAP; Pediaprophin; 4APR92 devel blotchy red rash on abd spreading to trunk & extremities;
Patient began feeling tightness in her throat, said she felt like she was being choked. Symptoms began around 1205. Able to continue talking and take sips of water. 50mg oral benadryl capsule given at  approximately 1210. Continued to speak with patient and reassess, sensation improved and then worsened after 10 minutes where patient was short of breath, needing to take frequent breaths and unable to easily hold conversation. 1221 epi pen administered and 911 called. Ambulance crew came and transferred patient to ER.
myasthenia gravesites; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-6-month-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "Goats milk allergy" (unspecified if ongoing), notes: Goats milk. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine and received other medications within 2 weeks of vaccination. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown., Location of injection: Arm Right), for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown.), for COVID-19 Immunization. The patient had no family history of myasthenia gravesites. Prior to vaccination, the patient was not diagnosed with COVID-19. The following information was reported: MYASTHENIA GRAVIS (hospitalization, disability, medically significant) with onset 24Feb2022, outcome "recovered with sequelae", described as "myasthenia gravesites". The patient was hospitalized for myasthenia gravis (hospitalization duration: 6 day(s)). The event "myasthenia gravesites" was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram of chest: no thymus involved. Therapeutic measures were taken as a result of myasthenia gravis, IV (intravenous) IEGg 5 doses steroids. Since the vaccination, the patient hadn't been tested for COVID-19. Lot unknown reason was misplaced/discarded.    The lot number for bnt162b2 was not provided and will be requested during follow up.
Vital Signs: BP 102/60 HR 86 Resp 20 O2sat 99 Skin Signs: Warm and dry, cool and dry initially  Respiratory: Breath sound clear bilaterally  Initial treatment: Pillow under head until she was awake and talking.  04:15 PM  Vital Signs: BP 108/60 HR 96 O2sat 99 Skin Signs: Warm and dry  Respiratory: Breath sound clear bilaterally  Drinking H2O  4:30 PM  Vital Signs: BP 104/58 HR 108 Resp 16 O2sat 99 Skin Signs: Warm and dry  Respiratory: Breath sound clear bilaterally  Follow up treatment: Recommended and assisted patient with calling for a ride home. Continued to feel alert and less anxious.  4:50 PM  AOx3. Denies N/V. Denies dizziness. BP 104/62 HR 90 Resp 18 O2sat 99 Left with friend
diabetic (type 1); not able to walk more than 5-10 min; started having debilitating pain; joint inflammation in the hip and knees; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  A 64 year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The patient was in good health prior to the vaccine. It was reported that the patient's sister was diabetic (Type 1). The following information was reported: TYPE 1 DIABETES MELLITUS (medically significant), outcome "unknown", described as "diabetic (type 1)"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "not able to walk more than 5-10 min"; PAIN (non-serious), outcome "unknown", described as "started having debilitating pain"; ARTHRITIS (non-serious), outcome "unknown", described as " joint inflammation in the hip and knees".  The lot number for bnt162b2 was not provided and will be requested during follow up.
I passed out on bathroom floor. Felt fatigued, had headache and was dizzy all day. Couldn?t get off couch
pt recvd vax & an elongated brown 6-7 inch spot devel @ the inject site; reaction abated w/in 1 wk;
Measles - like rash, low grade fever for about 5 days onset and then self-resolved.
Localized skin reaction and infection; Swelling, increased warmth, redness; Being treated with Keflex.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On 28-AUG-2018, the patient was vaccinated with an improperly stored dose of PROQUAD for prophylaxis, lot number R007684, expiration date on 11-SEP-2019 (strength, dose number, anatomical location and route of administration were not reported). The temperature excursion was from 6 degrees Fahrenheit (degrees F) to 14 degrees F for a time frame of 58 minutes without a previous temperature excursion and was called because a digital data logger. There was not adverse effect reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1809USA002675.
10 days after vaccine child developed malaise, fever and a maculopapular red rash that started on head spreading to trunk and extremities
Fever 100 started 2 days after Varicella vaccine given. Then on 8/11/08 vertigo symptoms began with 5-20 episodes per day. Vertigo still present as of 8/27/08 but less frequently, intermittent throughout the day.
Developed local red tiny bumps non vesicular non tender non painful B/L at site of shots AL thighs. Developed 101 fever next day of shot lasting 2 days. Cough next day too.
As the patient was walking out the door, after getting his vaccine, states, " It feels like my blood pressure is high".
Heavy period with large blood clots 10-12 times a day. On nexplanon birth control and have not experienced a period in years.  Lymph node swelling in armpit of the injected arm approximately 2 days after vaccinated
Body aches, migraine, and fever. Fever started off low grade in the morning, escalated to 104-105 by 2:00pm.  Tylenol helped reduce fever, fever broke around 7:30 pm.  Next day residual headache but was able to return to work.
Approximately 5 seconds after administering HPV vaccine in left deltoid to 20 year-old female, client veered sideways from a sitting position.  Nurse (myself) supported client back to an upright sitting position.  Client was pale and stated she felt "dizzy."  Client was instructed to place down head between legs. Nurse applied cold, wet towel to the back of client's neck.  Upon client's stating that syncope had resolved, nurse (myself) provided apple juice.  Client stated that she had eaten breakfast.  Client further stated that upon inspiration she "feels some pressure in my lower lungs," and client's color had not returned to her face.  Client displayed no signs of having difficulty breathing or speaking.  Client was helped to rest on exam table.  Nurse (myself) sought assistance from NP, who assessed client.  Client denied further symptoms of syncope and pressure in her lower lungs.  Nurse (myself) brought father into room from waiting room for parental support and explained the occurrence.  Father sat beside client for remainder of stay.  Upon confirmation that client denied further syncopal symptoms or pressure in lower lungs, nurse (myself) directed client to finish the apple juice.  Client was administered flu vaccine.  No further symptoms were reported.  Client remained under nursing supervision for 15 minutes lying prone and for 15 minutes on exam table in an upright sitting position.  Upon completion of waiting period, client denied syncope and pressure in lower lungs.  Color returned to her face.  Client stated that she "felt fine."  Client was released.
Lump at injection site "size of small hen egg" appeared next evening. Area pink and warm to touch and tender. Next AM (11/26/01) was still tender and inflamed. Went to Dr. and was given erythromycin. T/D x6 days. 11/29- Per client and area is  1cc swollen and only slightly red in center. No pain with arm movement.
c/o flu like sx;26JUL96 woke up w/dizziness, h/a & nausea;inj site no rxn noted;dx  by MD probable viral illness, possible rxn to hep B vax;
Diagnosed with PMR  Poly myalgia Rheunatica; This spontaneous case was reported by a consumer and describes the occurrence of POLYMYALGIA RHEUMATICA (Diagnosed with PMR  Poly myalgia Rheunatica) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced POLYMYALGIA RHEUMATICA (Diagnosed with PMR  Poly myalgia Rheunatica) (seriousness criterion medically significant). The patient was treated with NAPROXEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (ACETAMINOPHEN) for Adverse event, at an unspecified dose and frequency. At the time of the report, POLYMYALGIA RHEUMATICA (Diagnosed with PMR  Poly myalgia Rheunatica) outcome was unknown.            Patient experienced pain from her neck to her knees, any movement hurts. Patient stated that she had been diagnosed with PMR Poly myalgia Rheumatic by her neurologist.  Company Comment : This case concerns a 46-year-old, female patient with no medical history reported, who experienced the unexpected event of Polymyalgia rheumatica. The event occurred after the second dose of Spikevax. The rechallenge was negative since after the first dose the patient reported no adverse events. The benefit-risk relationship of Spikevax is not affected by this report.; Sender's Comments: This case concerns a 46-year-old, female patient with no medical history reported, who experienced the unexpected event of Polymyalgia rheumatica. The event occurred after the second dose of Spikevax. The rechallenge was negative since after the first dose the patient reported no adverse events. The benefit-risk relationship of Spikevax is not affected by this report.
Immediately, less in than 30 mins I felt something in. Y chest. A stuck or lump feeling. With this feeling was pain. A sense of pressure. Also lightheaded and out of sorts.  The stuck, lump feeling went away and returned on Sunday Sept 30 2021. Today is October 5 and I?m still having this feeling.
Blurred vision. Nauseous. Chills. Cold sweats. Mild fever. Sweating. Entire aching body down to my toes. Fatigue. Clouded mind. Extremely tired. Loss of appetite. Mild headache. Loss of concentration. Dizzy. Loss of balance. Chest pain radiating through back to shoulder blades. Quick loss of breath. Rapid heart beat.   I continue to take Tylenol every 6 hours until persists as directed by the RN that administered the vaccine.   Some side effects have lessened, others have not, and the rest seem to be slightly dissipating.
A few hours after the injection I had tingling and numbness in my left arm and hand.  As the day progressed the tingling and numbness also started in my left leg and I had a pain in the left side of my head (above my temple area).  I hoped that the next day these side effects would subside, but they have continued and I am now 4 days post injection.
I started having seizures, neuropathy, numbness, tingling, hives, severe joint pain, skin crawling, nausea, slurred speech, confusion. extreme fatigue, my eyes move at will (nystagmus), my balance and coordination is off. This comes in waves as this clears up and I feel I am getting better they come back as if in waves every 2 weeks to 30 days. I have been going different specialist for a year trying to pinpoint what is going on as I was perfect health  until I received the COVID-19 vaccine.
HIGH FEVER, INCREASED PULSE 90-100, DIZZINESS, WEAKNESS, CHILLS, VERY SEVERE HEADACHE AND INCREASED HIGH BLOOD PRESSURE 170/90. THE REACTION STARTED 3 AND 1/2 HOUR AFTER VACCINE.
mixed menveo with diluant and not liquid part of menveo; mixed menveo with diluant and not liquid part of menveo; This case was reported by a other health professional via sales rep and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional case details were provided as follows: The age at vaccination was not reported. Menveo was mixed with diluent and not liquid part of menveo which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter agreed to follow up. This case was 1 of 3 case reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR166884:same reporter US-GLAXOSMITHKLINE-US2021AMR166851:same reporter
Complaining of left upper arm pain and decreased range of motion with no redness and swelling secondary to tetanus vaccine given 2 weeks ago in this office.
shingles; Information has been received from a lawyer regarding a case in litigation and refers to a 65-year-old female patient (pt). There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 03-AUG-2017, pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not provided) for prophylaxis. Within one month after receiving zoster vaccine live (ZOSTAVAX), and as a result of her receipt of zoster vaccine live (ZOSTAVAX), pt was caused to suffer shingles, including any and all of its sequelae. A s a result of her receipt of zoster vaccine live (ZOSTAVAX), pt has been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Extreme Leg pain,, joint pain, 102 fever, entire body aching, just felt terrible. I was out of work for two days.
1 hour after vaccine I started to feel pain on the injection site and sore throat I was tired and dizzy and had fever and headache that lasted for 3 days and then I got a headache for another week. I had a rash on my right arm and it was painful for 2 weeks.
24 hrs after vaccine administered developed general malaise and fatigue. 48 hrs after vaccine, blotchy hives scattered over (L) upper arm. Applied ice pack PRN and took ZYRTEC qd. Symptoms started to improve on day 5 then fully resolved on day 7 after vaccine.